Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Reuters

21:14 EST 20th January 2019 | BioPortfolio

Here are the most relevant search results for "Reuters" found in our extensive news archives from over 250 global news sources.

More Information about Reuters on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reuters for you to read. Along with our medical data and news we also list Reuters Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reuters Companies for you to search.

Showing News Articles 1–25 of 2,600+ from Reuters

Sunday 20th January 2019

China reports African swine fever outbreak in Ningxia region

China's agriculture ministry on Sunday reported a new African swine fever outbreak in the northwestern region of Ningxia.

Friday 18th January 2019

Long-term exercise by older adults tied to lower risk of falls

(Reuters Health) - Older adults who have exercised regularly for at least a year may be less likely to experience falls or related injuries than their less active peers, a research review suggests.

Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod

The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.

For heart failure patients in hospital, flu boosts risk of complications, death

(Reuters Health) - When people with heart failure are hospitalized, having influenza is tied to greater odds of respiratory and kidney complications and a higher chance they won't survive to be discharged, a U.S. study suggests.

AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study

AbbVie Inc said on Friday its blockbuster cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer.

Shorter waits for new patients at VA than in private sector, U.S. study finds

(Reuters Health) - In many cases, veterans get a first appointment at VA hospitals quicker than the general public gets first appointments with health care providers, government researchers report.

AbbVie's cancer drug fails to meet main goal in late-stage study

AbbVie Inc said on Friday its cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer.

Insomnia treatment may help ease depression during menopause

(Reuters Health) - Women going through menopause may have fewer symptoms of depression when they get treatment for insomnia than when they don't, a recent experiment suggests.

Study links opioid epidemic to painkiller marketing

(Reuters Health) - Researchers are reporting a link between doctor-targeted marketing of opioid products and the increase in U.S. deaths from overdoses.

Samsung Bioepis-Merck biosimilar to Roche's Herceptin wins FDA nod

The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin.

Lilly cancer drug fails key trial, will no longer be prescribed

Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and will no longer be prescribed, driving the drugmaker's shares down nearly ...

Lilly's cancer therapy Lartruvo fails study, shares drop

Eli Lilly and Co said its cancer treatment Lartruvo failed to meet the main goal in a late-stage trial and it expects to take a charge in the first quarter of 2019, sending its shares down more than 2 percent in early trade.

Thursday 17th January 2019

Immunomedics' cancer treatment fails to win accelerated approval from the FDA

Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment, sacituzumab.

FDA advisory panel split over Sanofi-Lexicon diabetes drug

Independent experts on an FDA advisory panel were equally split when voting on whether to approve an oral treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France's Sanofi SA.

Doctors explain misconceptions about penicillin allergy

(Reuters Health) - Most patients who report having a penicillin allergy are not really allergic to this highly effective antibiotic, and they may be missing out on the best treatment for their condition as a result, according to a new patient resourc...

Long-lasting menopause symptoms may be tied to slightly higher breast cancer risk

(Reuters Health) - Women who experience symptoms of menopause, like hot flashes or night sweats, for many years may be slightly more likely to develop breast cancer than women who never had these symptoms, a U.S. study suggests.

Junk food ads disproportionately target black and Hispanic kids: report

(Reuters Health) - Television advertising in the U.S. for candy, fast food, sugary drinks and other unhealthy treats continues to target mostly black and Hispanic youth, according to a new report that suggests this contributes to health disparities. ...

Too little sleep tied to increased heart disease risk

(Reuters Health) - People who sleep less than six hours a night may be more likely to develop cardiovascular disease than those who sleep seven to eight hours, a Spanish study suggests.

Invest in health for global security and growth, Gates urges donors

Donating billions of dollars to global funds that fight poverty and disease is one of the best investments governments can make to boost security and economic growth, philanthropists Bill and Melinda Gates said on Thursday.

Wednesday 16th January 2019

Japan Tobacco ratchets up smokeless war with new products

Japan Tobacco Inc on Thursday unveiled two "heat-not-burn" products, as it races against market leader Philip Morris International Inc for a larger share of the vaping space with conventional cigarettes steadily falling out of favor.

Scientists reveal 'ideal diet' for peoples' and planet's health

Scientists have unveiled what they say is an ideal diet for the health of the planet and its people - including a doubling of consumption of nuts, fruits, vegetables and legumes, and a halving of meat and sugar intake.

Slim but sedentary might face same heart risks as overweight

(Reuters Health) - Adults with a healthy weight but a sedentary lifestyle may have the same risk for heart attacks or strokes as people who are overweight, a recent study suggests.

Hearing aid users often do not see doctors to ensure devices help

(Reuters Health) - In 2020, a new U.S. law will allow people to buy hearing aids over-the-counter, but that may not improve access to hearing care, a new study suggests.

U.S. shutdown taking toll on FDA, USDA inspection roles: experts

The partial government shutdown is taking a toll on key safety inspection duties performed by the U.S. Food and Drug Administration and Department of Agriculture, food safety experts said on Wednesday.

Australia's aged care sector braces for powerful inquiry

A public inquiry into mistreatment of the elderly in Australia's A$20 billion ($14 billion) aged-care industry begins hearings on Friday, with investors expecting damaging testimony to be followed by tighter regulation and a possible sector shakeout....


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks